RESUMO
Increased blood pressure is a leading risk factor for death worldwide, and improving the control of hypertension is a major health goal to reduce non-communicable disease. Thus, in 2016, as part of a regional effort between the Pan American Health Organization and Cuban Ministry of Public Health to reduce cardiovascular risk and disease, a community demonstration project was implemented to enhance hypertension control. The intervention project was in a population of 25 868 people served by the Carlos Verdugo Martínez Polyclinic in Matanzas, Cuba. The project implemented interventions currently recommended in the World Health Organization HEARTS modules, including a standardized clinical training program with certification for blood pressure measurement, routine screening for hypertension in clinics and in the community, a simple directive pharmacologic treatment algorithm, and a registry with performance reporting and feedback. Qualitative and quantitative program monitoring and evaluation was established. In a 2010 national survey, the prevalence of hypertension and the rate of hypertension control were estimated to be 31% and 36%, respectively. Following less than one year of the full implementation of the program, the prevalence of hypertension, proportion of the hypertensive population registered as having hypertension, proportion of those drug-treated who were controlled, and estimated population rate of control were 30%, 90%, 68%, and 58%, respectively. Based on these positive results, the program has been expanded to include another demonstration program initiated in a second region. In addition, preliminary efforts to disseminate and scale-up aspects of the program to the full Cuban population have started.
Assuntos
Hipertensão , Determinação da Pressão Arterial , Cuba/epidemiologia , Humanos , Hipertensão/diagnóstico , Hipertensão/tratamento farmacológico , Hipertensão/epidemiologia , Organização Pan-Americana da Saúde , Organização Mundial da SaúdeRESUMO
RESUMEN El control de la hipertensión arterial resulta la medida más efectiva para lograr disminuir la mortalidad total. Una propuesta de actualidad para alcanzar ese propósito es la implementación de regímenes de tratamiento estandarizados, asociados a la prevención secundaria de la cardiopatía isquémica. En este sentido es importante el acceso del paciente a los medicamentos, el trabajo en equipo y la vigilancia del control de la presión arterial y del progreso de los pacientes que reciben el tratamiento, para ello el monitoreo y la evaluación son elementos fundamentales.
ABSTRACT The arterial hypertension control is the most effective measure to reach the decrease of the total mortality. A current proposal to reach this goal is the implementation of standardized treatment regimes, associated to the secondary prevention of the ischemic heart disease. In this sense it is important the access of the patient to the medicines, the team work and the surveillance of the arterial pressure control and the progress of the patients receiving treatment, for what monitoring and assessment are main elements.
Assuntos
Humanos , Planos e Programas de Saúde , Isquemia Miocárdica/mortalidade , Isquemia Miocárdica/prevenção & controle , Hipertensão/mortalidade , Hipertensão/prevenção & controle , Artigo de RevistaRESUMO
RESUMEN El control de la hipertensión arterial resulta la medida más efectiva para lograr disminuir la mortalidad total. Una propuesta de actualidad para alcanzar ese propósito es la implementación de regímenes de tratamiento estandarizados, asociados a la prevención secundaria de la cardiopatía isquémica. En este sentido es importante el acceso del paciente a los medicamentos, el trabajo en equipo y la vigilancia del control de la presión arterial y del progreso de los pacientes que reciben el tratamiento, para ello el monitoreo y la evaluación son elementos fundamentales (AU).
ABSTRACT The arterial hypertension control is the most effective measure to reach the decrease of the total mortality. A current proposal to reach this goal is the implementation of standardized treatment regimes, associated to the secondary prevention of the ischemic heart disease. In this sense it is important the access of the patient to the medicines, the team work and the surveillance of the arterial pressure control and the progress of the patients receiving treatment, for what monitoring and assessment are main elements (AU).
